Drug-induced arrhythmias

被引:47
|
作者
Barnes, Brian J. [1 ]
Hollands, James M. [2 ]
机构
[1] Univ Kansas, Med Ctr, Sch Pharm, Kansas City, KS 66103 USA
[2] Barnes Jewish Hosp, Dept Pharm, St Louis, MO 63110 USA
关键词
drug-induced; arrhythmias; risk factors; QT interval; antiarrhythmics; inotropes; digoxin; electrolyte imbalances; anesthetic agents; bronchodilators; patient safety; LONG-QT SYNDROME; VOLATILE ANESTHETICS; HEART-FAILURE; ELECTROCARDIOGRAPHIC MANIFESTATIONS; VENTRICULAR-ARRHYTHMIAS; INTRAVENOUS MILRINONE; MYOCARDIAL-INFARCTION; INDUCED PROLONGATION; GENERAL-ANESTHESIA; RISK-FACTORS;
D O I
10.1097/CCM.0b013e3181de112a
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The objective of this review is to characterize the mechanisms, risk factors, and offending pharmacotherapeutic agents that may cause drug-induced arrhythmias in critically ill patients. PubMed, other databases, and citation review were used to identify relevant published literature. The authors independently selected studies based on relevance to the topic. Numerous drugs have the potential to cause drug-induced arrhythmias. Drugs commonly administered to critically ill patients are capable of precipitating arrhythmias and include antiarrhythmics, antianginals, antiemetics, gastrointestinal stimulants, antibacterials, narcotics, antipsychotics, inotropes, digoxin, anesthetic agents, bronchodilators, and drugs that cause electrolyte imbalances and bradyarrhythmias. Drug-induced arrhythmias are insidious but prevalent. Critically ill patients frequently experience drug-induced arrhythmias; however, enhanced appreciation for this adverse event has the potential to improve prevention, treatment, patient safety, and outcomes in this patient population. (Crit Care Med 2010; 38[Suppl.]:S188-S197)
引用
收藏
页码:S188 / S197
页数:10
相关论文
共 50 条
  • [1] Pharmacogenetics of drug-induced arrhythmias
    Abbott, Geoffrey W.
    Roepke, Torsten K.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2008, 1 (01) : 93 - 104
  • [2] Pharmacogenetics and drug-induced arrhythmias
    Roden, DM
    CARDIOVASCULAR RESEARCH, 2001, 50 (02) : 224 - 231
  • [4] Genetic basis of drug-induced arrhythmias
    Vos, MA
    Paulussen, ADC
    ANNALS OF MEDICINE, 2004, 36 : 35 - 40
  • [5] An international registry for drug-induced arrhythmias
    Waterworth C.
    Critical Care, 4 (1):
  • [6] DRUG-INDUCED ARRHYTHMIAS AS A WINDOW TO PHARMACOGENOMICS
    Roden, Dan M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 97 : S2 - S2
  • [7] THE ROLE OF THE PURKINJE SYSTEM IN DRUG-INDUCED ARRHYTHMIAS
    Corrias, Alberto
    Burrage, Kevin
    Rodriguez, Blanca
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 131 - 131
  • [8] A 2015 focus on preventing drug-induced arrhythmias
    Bossu, A.
    van der Heyden, M. A. G.
    de Boer, T. P.
    Vos, M. A.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2016, 14 (02) : 245 - 253
  • [9] Channel structure and drug-induced cardiac arrhythmias
    Kass, RS
    Cabo, C
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) : 11683 - 11684
  • [10] An update on risk factors for drug-induced arrhythmias
    Vlachos, Konstantinos
    Georgopoulos, Stamatis
    Efremidis, Michael
    Sideris, Antonios
    Letsas, Konstantinos P.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (01) : 117 - 127